# A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

> clinical trial · VERIFIED · 2026-08-13

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Relapsing Multiple Sclerosis

- Company: Hoffmann-La Roche
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT04586010

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.